We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Center Bancorp
CNOB
$1.78B
| $2.51M | ﹤0.01% |
80,950
-2,304
| -3% | -$77.1K |
|
1402
Matsons
MATX
$6.11B
| $2.51M | ﹤0.01% |
27,425
+7,843
| +40% | +$790K |
|
|
PANA
1403
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $2.49M | ﹤0.01% |
254,920
-3,610
| -1% | -$35K |
|
1404
Alkermes
ALKS
$8.25B
| $2.48M | ﹤0.01% |
86,070
-38,714
| -31% | -$959K |
|
|
X
1405
DELISTED
US Steel
X
| $2.46M | ﹤0.01% |
80,557
+25,113
| +45% | +$679K |
|
1406
Bowman Consulting
BWMN
$742M
| $2.45M | ﹤0.01% |
149,255
+1,705
| +1% | +$30.2K |
|
1407
Colony Bankcorp
CBAN
$465M
| $2.44M | ﹤0.01% |
133,299
+103,841
| +353% | +$1.87M |
|
|
SGI
1408
Somnigroup International
SGI
$14B
| $2.44M | ﹤0.01% |
90,081
-59,216
| -40% | -$2.18M |
|
1409
Protolabs
PRLB
$2.17B
| $2.43M | ﹤0.01% |
47,906
+15,863
| +50% | +$835K |
|
|
XRN
1410
Chiron Real Estate Inc
XRN
$471M
| $2.43M | ﹤0.01% |
30,862
-108
| -0.3% | -$8.84K |
|
1411
Haemonetics
HAE
$3.97B
| $2.43M | ﹤0.01% |
41,516
+34,898
| +527% | +$1.9M |
|
1412
Cavco Industries
CVCO
$4.51B
| $2.42M | ﹤0.01% |
10,252
-22,432
| -69% | -$6.19M |
|
1413
Crinetics Pharmaceuticals
CRNX
$8.94B
| $2.42M | ﹤0.01% |
110,278
-4,490
| -4% | -$90.9K |
|
1414
Amdocs
DOX
$6.22B
| $2.41M | ﹤0.01% |
30,285
| – | – |
|
1415
Cathay General Bancorp
CATY
$4.24B
| $2.4M | ﹤0.01% |
59,870
-378,025
| -86% | -$17.4M |
|
1416
Hawkins
HWKN
$2.72B
| $2.38M | ﹤0.01% |
54,031
+44,008
| +439% | +$1.85M |
|
1417
AGNC Investment
AGNC
$12.8B
| $2.36M | ﹤0.01% |
214,942
-15,382
| -7% | -$215K |
|
|
PLYM
1418
DELISTED
Plymouth Industrial REIT
PLYM
| $2.35M | ﹤0.01% |
90,332
+15,128
| +20% | +$417K |
|
|
AZPN
1419
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.35M | ﹤0.01% |
14,813
+6,426
| +77% | +$1.02M |
|
1420
Enova International
ENVA
$6.37B
| $2.34M | ﹤0.01% |
62,471
+33
| +0.1% | +$1.32K |
|
1421
Southern Copper
SCCO
$163B
| $2.31M | ﹤0.01% |
40,474
-385
| -0.9% | -$24.4K |
|
1422
Concrete Pumping Holdings
BBCP
$473M
| $2.31M | ﹤0.01% |
344,511
-67,231
| -16% | -$516K |
|
1423
Origin Bancorp
OBK
$1.66B
| $2.31M | ﹤0.01% |
55,997
-663
| -1% | -$29K |
|
|
SYNH
1424
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.3M | ﹤0.01% |
31,477
+10,405
| +49% | +$880K |
|
|
DALS
1425
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $2.3M | ﹤0.01% |
235,925
-3,960
| -2% | -$38.2K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.